The Contributions Of Oncotarget To The Advancement Of Medical Research

Oncotarget is an American multidisciplinary journal that aims to help authors to boost the reach and impression of their published works. The journal specializes in the publication of research papers, case studies, reviews, books, and editorials that touch on oncology, pathology, age-related diseases, and endocrinology.

However, the success enjoyed by Oncotarget has enabled them to expand their research base to fields such as cardiology, cell biology, metabolism, neuroscience, pharmacology, and much more. The journal publishes weekly papers and helps researchers to advance the course of science in creating a life without diseases.

Oncotarget allows for the quick sharing of extraordinary research findings. The insightful peer review mechanism and advisory boards ensure that publications are unbiased, not manipulated and are of the highest quality standards. Download output styles at Endnote.com.

Since 2010, it has been published by Impact Journals and is under the leadership of distinguished scientists such as Mikhail Blagosklonny, the editor-in-chief. He is a specialist in oncology and anti-aging medicine at the Roswell Park Cancer Center in New York. He has published over 270 papers that have gathered more than 25,000 citations in peer-reviewed journals.

Oncotarget features as one of the renowned journals in the U.S with over 10,000 citations and an impact factor of 5.008 between 2015 and 2016. In 2015, the journal received the highest ranking from Scopus with a Q1 rank and five-year impact factor of 5.415 in oncology and general medicine.

It operates using an open access business model that provides the basis for its scholarly journals to be made available online without any legal, financial or technical impediments other than those associated with accessing the internet.

The journal, however, supports itself through submission fees that are unique to the type of entry a researcher wants to publish. The submission fees sustain the open access model and are used to cater for expenses such as legal and ethical costs, online archiving and hosting, dissemination and promotion of publications, investigation of data manipulation and plagiarism, as well as protecting the integrity of the publications and the journal as a whole.

Article submissions are done through an online system, and Oncotarget implements the Creative Commons Attribution License. This license enables authors to maintain ownership of all copyrights. However, no permission is required from the author when another individual wants to reuse or redistribute the publication. The only requirement is to cite the source, and this allows work to be freely and openly accessible . Oncotarget, which is published by Impact Journals